Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06998134 · ClinicalTrials.gov registry record
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
A clinical trial of Muscle Weakness and Problems Moving Their Arms and Legs, sponsored by National Institutes of Health Clinical Center (CC).
- Recruiting
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT06998134 is a study of Muscle Weakness and Problems Moving Their Arms and Legs that is actively recruiting participants, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 23 participants, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06998134, a study of Muscle Weakness and Problems Moving Their Arms and Legs, is actively recruiting participants, sponsored by National Institutes of Health Clinical Center (CC).
- RECRUITING
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
People with cerebral palsy (CP), muscular dystrophy (MD), spina bifida, or spinal cord injury often have muscle weakness, and problems moving their arms and legs. The NIH designed a new brace device, called an exoskeleton, that is worn on the legs and helps people walk. This study is investigating new ways the exoskeleton can be used in multiple settings while performing different walking or movement tasks, which we call ubiquitous use. For example, we will ask you to walk on a treadmill at different speeds, walk up and down a ramp, or walk through an obstacle course. Optionally, the exoskeletons may also use functional electrical stimulation (FES), a system that sends electrical pulses to the muscle to help it move the limb.
Conditions Studied
Interventions
- DEVICE Extension assist knee ankle foot orthosis (EA-KAFO)
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2026-03-26 |
| Est. Completion | 2028-08-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06998134
The ClinicalTrials.gov registry entry for NCT06998134 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (69% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 1 intervention - of which Extension assist knee ankle foot orthosis (EA-KAFO) is the first listed.
NCT06998134 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06998134 about?
NCT06998134 is a clinical study titled "Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults". People with cerebral palsy (CP), muscular dystrophy (MD), spina bifida, or spinal cord injury often have muscle weakness, and problems moving their arms and legs. The NIH designed a new brace device, called an exoskeleton, that is worn on the legs and helps people walk. This study is investigating n...
What is the current status of trial NCT06998134?
This trial is currently recruiting. The enrollment target is 23 participants. The study started on 2026-03-26. Estimated completion is 2028-08-18.
What conditions does trial NCT06998134 study?
This clinical trial studies the following conditions: Muscle Weakness, Problems Moving Their Arms and Legs.
What interventions are being tested in trial NCT06998134?
The interventions under investigation include: Extension assist knee ankle foot orthosis (EA-KAFO) (DEVICE).
Who is sponsoring clinical trial NCT06998134?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06998134 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
FIT Exercise in 30d of ULLS-induced Muscle Disuse
RECRUITING · NA
-
Muscle Recovery After Critical Illness
RECRUITING
-
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RECRUITING · NA
-
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RECRUITING · Phase 1
-
Depo-Medrol on Psoas After LLIF
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.